RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
GlaxoSmithKline Stock

GlaxoSmithKline Equity 2024

GlaxoSmithKline Equity

13.35 B GBP

Ticker

GSK.L

ISIN

GB0009252882

WKN

940561

In 2024, GlaxoSmithKline's equity was 13.35 B GBP, a 25.94% increase from the 10.6 B GBP equity in the previous year.

GlaxoSmithKline Aktienanalyse

What does GlaxoSmithKline do?

GlaxoSmithKline PLC is a globally leading pharmaceutical company headquartered in London, UK. The company's history dates back to 1873 when the Burroughs Wellcome & Co firm was founded. In 2000, the company merged with Glaxo Wellcome to form the current GlaxoSmithKline PLC. GlaxoSmithKline's business model is to provide medical solutions for various diseases and health problems. The company heavily invests in research and development to develop new drugs and vaccines. It collaborates closely with government agencies, hospitals, doctors, and patient organizations to ensure better access to its products. The company is divided into three different divisions: Pharma, Vaccines, and Consumer Healthcare. The Pharma division is the largest and includes areas such as oncology, immunology, neuroscience, respiratory, and infectious diseases. GlaxoSmithKline is a leader in HIV treatment and is also active in the development of cancer drugs. The Vaccines division of GlaxoSmithKline is also very large and includes vaccines against various infectious diseases such as pneumococcus, influenza, and meningitis. It is also working on the development of vaccines against COVID-19. GlaxoSmithKline's Consumer Healthcare division includes products such as Sensodyne, Voltaren, Nicotinell, and Aquafresh. These products operate in the areas of oral health, pain relief, and smoking cessation. The focus is on a wide range of over-the-counter products available in pharmacies and supermarkets. An example of an important product of GlaxoSmithKline is the malaria vaccine developed in collaboration with the University of Oxford. The vaccine has the potential to save millions of lives in Africa. Currently, the vaccine is being tested in several African countries. GlaxoSmithKline PLC has also faced some controversies in the past, particularly related to the marketing of antidepressants. However, the company has taken measures to increase the transparency of its practices and operate ethically. Overall, GlaxoSmithKline is a significant pharmaceutical company that offers a wide range of medical products and solutions. It heavily invests in research and development to develop new products that can improve people's lives. The company also adopts an ethical approach in its business and advocates for better access to its products. GlaxoSmithKline ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Equity Details

Analyzing GlaxoSmithKline's Equity

GlaxoSmithKline's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding GlaxoSmithKline's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating GlaxoSmithKline's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

GlaxoSmithKline's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in GlaxoSmithKline’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about GlaxoSmithKline stock

What is the equity of GlaxoSmithKline this year?

GlaxoSmithKline has equity of 13.35 B GBP this year.

What was the equity of GlaxoSmithKline compared to the previous year?

The equity of GlaxoSmithKline has increased/decreased by 25.94% increased compared to the previous year.

What impact does a high equity have on investors of GlaxoSmithKline?

A high equity is advantageous for investors of GlaxoSmithKline as it is an indicator of the company's financial stability and its ability to manage risks and challenges.

What impact does low equity have on investors of GlaxoSmithKline?

A low equity can be a risk for investors of GlaxoSmithKline, as it can put the company in a weaker financial position and impair its ability to manage risks and challenges.

How does an increase in equity of GlaxoSmithKline affect the company?

An increase in equity of GlaxoSmithKline can strengthen the company's financial position and improve its ability to make investments in the future.

How does a reduction in the equity of GlaxoSmithKline affect the company?

A reduction in equity of GlaxoSmithKline can affect the financial situation of the company and lead to a higher dependence on debt capital.

What are some factors that influence the equity of GlaxoSmithKline?

Some factors that can affect the equity of GlaxoSmithKline include profits, dividend payments, capital increases, and acquisitions.

Why is the equity of GlaxoSmithKline so important for investors?

The equity of GlaxoSmithKline is important for investors as it is an indicator of the financial strength of the company and can be an indication of how well the company is able to fulfill its financial obligations.

What strategic measures can GlaxoSmithKline take to change the equity?

To change equity, GlaxoSmithKline can take various measures such as increasing profits, conducting capital increases, reducing expenses, and acquiring companies. It is important for the company to perform a thorough review of its financial situation to determine the best strategic actions to modify its equity.

How much dividend does GlaxoSmithKline pay?

Over the past 12 months, GlaxoSmithKline paid a dividend of 0.56 GBP . This corresponds to a dividend yield of about 4.22 %. For the coming 12 months, GlaxoSmithKline is expected to pay a dividend of 1.04 GBP.

What is the dividend yield of GlaxoSmithKline?

The current dividend yield of GlaxoSmithKline is 4.22 %.

When does GlaxoSmithKline pay dividends?

GlaxoSmithKline pays a quarterly dividend. This is distributed in the months of March, June, September, December.

How secure is the dividend of GlaxoSmithKline?

GlaxoSmithKline paid dividends every year for the past 26 years.

What is the dividend of GlaxoSmithKline?

For the upcoming 12 months, dividends amounting to 1.04 GBP are expected. This corresponds to a dividend yield of 7.9 %.

In which sector is GlaxoSmithKline located?

GlaxoSmithKline is assigned to the 'Health' sector.

Wann musste ich die Aktien von GlaxoSmithKline kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of GlaxoSmithKline from 1/9/2025 amounting to 0.15 GBP, you needed to have the stock in your portfolio before the ex-date on 11/14/2024.

When did GlaxoSmithKline pay the last dividend?

The last dividend was paid out on 1/9/2025.

What was the dividend of GlaxoSmithKline in the year 2023?

In the year 2023, GlaxoSmithKline distributed 0.67 GBP as dividends.

In which currency does GlaxoSmithKline pay out the dividend?

The dividends of GlaxoSmithKline are distributed in GBP.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The GlaxoSmithKline stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank

Andere Kennzahlen von GlaxoSmithKline

Our stock analysis for GlaxoSmithKline Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GlaxoSmithKline Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.